MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $956,000 | +26.6% | 500,000 | 0.0% | 0.37% | +25.9% |
Q3 2014 | $755,000 | +13.7% | 500,000 | 0.0% | 0.30% | +16.5% |
Q2 2014 | $664,000 | +30.7% | 500,000 | 0.0% | 0.26% | +26.9% |
Q1 2014 | $508,000 | -51.1% | 500,000 | -50.0% | 0.20% | -52.3% |
Q4 2013 | $1,038,000 | +14.1% | 1,000,000 | 0.0% | 0.42% | +10.8% |
Q3 2013 | $910,000 | – | 1,000,000 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 16,490,000 | $25,947,000 | 12.49% |
SILVERBACK ASSET MANAGEMENT LLC | 14,500,000 | $22,711,000 | 2.37% |
TANG CAPITAL MANAGEMENT LLC | 3,500,000 | $5,259,000 | 1.94% |
ARISTEIA CAPITAL, L.L.C. | 11,932,000 | $18,727,000 | 0.95% |
WOLVERINE ASSET MANAGEMENT LLC | 12,600,000 | $19,576,000 | 0.46% |
Polar Capital LLP | 3,120,000 | $4,965,000 | 0.10% |
Tekla Capital Management LLC | 1,485,000 | $2,336,000 | 0.08% |
MIZUHO SECURITIES USA LLC | 194,000 | $305,000 | 0.08% |
PALISADE CAPITAL MANAGEMENT, LP | 1,410,000 | $2,206,000 | 0.06% |
LAZARD ASSET MANAGEMENT LLC | 11,010,000 | $17,375,000 | 0.04% |